Brokerage firm analysts are predicting that Natus Medical Incorporated (NASDAQ:BABY) will grow at an accelerated rate over the next five years. Sell-side analysts are looking for the company to grow 22.01% over the next year and 22.00% over the next five years.
Natus Medical Incorporated (NASDAQ:BABY)’s trailing 12- months EPS is -0.07. Last year, their EPS growth was 12.90% and their EPS growth over the past five years was 39.60%.
Let’s start off by taking a look at how the stock has been performing recently. Over the past twelve months, Natus Medical Incorporated (NASDAQ:BABY)’s stock was 17.82%. Last week, it was -4.32%, 20.06% over the last quarter, and 20.23% for the past half-year.
Over the past 50 days, Natus Medical Incorporated stock was -5.85% off of the high and 25.54% removed from the low. Their 52-Week High and Low are noted here. -6.39% (High), 29.70%, (Low).
Natus Medical Incorporated (NASDAQ:BABY)’s performance this year to date is 17.82%. The stock has performed -4.32% over the last seven days, 2.24% over the last thirty, and 20.06% over the last three months. Over the last six months, Natus Medical Incorporated’s stock has been 20.23% and 1.36% for the year.
FUTURE GROWTH ESTIMATES AND RECOMMENDATIONS
Wall Street analysts are have a consensus analyst recommendation of 2.00 on the stock. This is based on a 1-5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Brokerages covering the name have a $55.00 on the stock.
The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs. Where quoted, past performance is not indicative of future performance.